Live
- NASA Tracks Five Giant Asteroids on Close Approach to Earth Today
- Pushpa 2 Hits ₹1000 Crore in 6 Days: How It Compares to Other Top Indian Films
- Vivo X200 and X200 Pro Launched in India: Price, Specifications, and Features
- Nitin Gadkari Admits Feeling Embarrassed at Global Summits Over Rising Road Accidents in India
- Comprehensive Review on Indiramma Housing Survey and Welfare Initiatives Conducted via Video Conference
- Jogulamba Temple Records Rs 1.06 Crore Hundi Revenue in 150 Days
- Opposition Slams ‘One Nation, One Election’ Bill as Anti-Democratic; BJP Allies Support the Move
- Celebrate Karthigai Maha Deepam Virtually with Sri Mandir’s LIVE Darshan Experience
- BJP Extends Support to Samagra Shiksha Abhiyan Employees' Strike, Demands Immediate Regularization and Welfare Benefits
- Dr. M. Priyanka Stresses Quality Education, Nutritious Meals, and Cleanliness in Schools
KTR extends wishes to Hyderabad biotech firm to develop vaccine for coronavirus
Telangana minister KT Rama Rao extended best wishes to Hyderabad biotech company Bharat Biotech which is striving to develop the 'CoroFlu' vaccine for the prevention of coronavirus.
Telangana minister KT Rama Rao extended best wishes to Hyderabad biotech company Bharat Biotech which is striving to develop the 'CoroFlu' vaccine for the prevention of coronavirus. The minister greeted the company managing director Dr. Krishna Ella and the team in the development of the vaccine.
My best wishes to our own Hyderabad Biotech company @BharatBiotech as they strive to develop a vaccine #CoroFlu for #CoronaVirus prevention
— KTR (@KTRTRS) April 4, 2020
Good luck in your endeavour CMD Dr. Krishna Ella and team. Wish you all success 👍 pic.twitter.com/Ivd1t3KePf
Bharat Biotech Ltd, a Hyderabad-based firm has joined hands with the University of Wisconsin-Madison and US-based company FluGen to develop 'CoroFlu'. The company said that the vaccine will be based on FluGen's flu vaccine candidate M2SR. "The gene sequences from coronavirus SARS-CoV2 will be placed into the vaccine candidate for additional immunity to fight against coronavirus," Bharat Biotech said.
Raches Ella, managing director of Bharat Biotech in a statement said that the company would produce 300 million doses of vaccine for global distribution.
